| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
Vaccines’ Alum Adjuvant Path to Brain Found: Study
Newly published research by Keele Conference scientists shows that aluminum adjuvant in vaccines transfers to the brain. They have documented the path from injection site to the brain, and that once in the brain, it persists. Newborns, the elderly, and people with a certain genetic variation are particularly at risk.
OK Aluminum Eye by Audrey (cropped), Skull & Crossbones Added
by Heidi Stevenson
A new study adds a major link in the association of aluminum adjuvants in vaccines with neurological disorders. It demonstrates the pathway along which aluminum in vaccine adjuvants is transferred from the injection site to the brain, where it persists indefinitely. They have also identified a likely carrier and a means by which the process occurs.
The study is exhaustive, eliminating a wide array of options that might mitigate against their findings. They also focused on two groups to determine if their findings indicate that they’re at particular risk. They include newborns and people with a certain genetic variant. On top of that, the elderly may be at significantly higher risk for aluminum adjuvant-induced neurotoxic harm.
Please note that variant does not mean defective! We all have genes that are not like those of the majority. That does not indicate a defect, only a distinction. Viva la difference!
Reason for the Study
Nanoparticles are not as new in medicine as generally believed. The study states:
The use of nanomaterials in humans is not as contemporary as is recently portrayed. For decades, alum, a nanocrystalline compound formed of aluminum oxyhydroxide, has been the most commonly used adjuvant in vaccines.
Philosophers stone – selected views from the boat
http://philosophers-stone.co.uk
2013-04-14 12:20:18
Source: http://philosophers-stone.co.uk/wordpress/2013/04/vaccines-alum-adjuvant-path-to-brain-found-study/
Source:
